Looks like the Patrick Kelly 11THREE Capital Deck, isn't generating any funds for any type launch as of 07/20/2026. Before a fund/investor even hops on a phone call, an analyst will run the patent numbers through a database like Espacenet or the USPTO registry. They check the patent application number, WO2021091916A1 and instantly see the status: Ceased/Abandoned.
A search for "11 Three LLC" returns zero active entities. A modified search finds 11THREE LLC (Company Number W25714858) registered only a year ago, with David Waterman listed as the sole agent and an incubator co-working space as the address. Then a search the FDA National Drug Code directory for the RELIEFTA™ patch. You find it listed under the explicit, unapproved category used for administrative tracking, not medical validation.
Then you find that the product cannot legally be marketed as an insurance-reimbursable prescription drug, completely invalidating the multi-million-dollar financial projections in the pitch deck.
The Pitch Deck promises "immediate access to 60,000 independent pharmacies via CentennialRx, Mirage" an analyst reviews the Delaware corporate filings and pharmacy board licenses. They discover CentennialRx is simply a corporate filing name, completely separate from the actual, localized brick-and-mortar pharmacy operations required to legally move drugs.
The fund recognizes that the "60,000 pharmacy network" is a theoretical marketing concept rather than an exclusive, contractually bound distribution pipeline.
PL
A search for "11 Three LLC" returns zero active entities. A modified search finds 11THREE LLC (Company Number W25714858) registered only a year ago, with David Waterman listed as the sole agent and an incubator co-working space as the address. Then a search the FDA National Drug Code directory for the RELIEFTA™ patch. You find it listed under the explicit, unapproved category used for administrative tracking, not medical validation.
Then you find that the product cannot legally be marketed as an insurance-reimbursable prescription drug, completely invalidating the multi-million-dollar financial projections in the pitch deck.
The Pitch Deck promises "immediate access to 60,000 independent pharmacies via CentennialRx, Mirage" an analyst reviews the Delaware corporate filings and pharmacy board licenses. They discover CentennialRx is simply a corporate filing name, completely separate from the actual, localized brick-and-mortar pharmacy operations required to legally move drugs.
The fund recognizes that the "60,000 pharmacy network" is a theoretical marketing concept rather than an exclusive, contractually bound distribution pipeline.
PL
1
